Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
Part of paid clinical trials in Newport, Rhode Island.
- Sponsor
- Women and Infants Hospital of Rhode Island
- Study ID
- NCT06842875
- Status
- Recruiting
Conditions
- Hypertension in Pregnancy
- Postpartum Complication
- Postpartum Preeclampsia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- RI-SPHERES — BEHAVIORALParticipants assigned to the RI-SPHERES group will be introduced virtually or in-person to the care manager (CM), who demonstrate how to communicate directly with patients through the app for medical or non-medical needs. Each participant will learn how to obtain SMBP, sync the LTE-enabled BP cuff to the RI-SPHERES app, and respond to adaptive messaging pertaining to BP measurements, which include the ability to receive on-demand education on postpartum topics (e.g., HDP, breastfeeding, mood disorders) per participant preference. During the study period, the CM will respond to needs elicited from the SDoH screening by facilitating referrals to community resources. After six weeks, the focus of RI-SPHERES will transition to preventive care in addition to SMBP. The CM will engage monthly with each study participant to ensure they have a primary care provider and to facilitate preventive care visits or specialist appointments, if needed.
- Standard self-measured blood pressure program — BEHAVIORALParticipants assigned to the routine care group meet virtually or in-person with a member of WIH's existing SMBP program and enroll in WIH's EPIC MyChart Portal to allow the SMBP program to receive patient-entered BP measurements and respond to messages. Participants will be provided with BP cuffs and taught how to obtain SMBP and report their BP through MyChart. At six weeks postpartum, WIH SMBP staff send a MyChart message to recommend BP ascertainment once per month and to describe the importance of attending a clinical visit with a primary care provider within a year of birth.
Study Details
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
Key Dates
- Start date
- Apr 15, 2025
- Status verified
- Feb 2025
- Primary completion
- Mar 1, 2029
- Completion
- Mar 1, 2029
Study Design
- Enrollment
- 1,536 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: RI-SPHERESA technology enabled collaborative care model. Participants will receive a LTE-enabled blood pressure (BP) cuff that syncs to a smartphone application (app) to send automated reminders and provide adaptive messaging tailored to distinct BP values and symptoms. The first six weeks of the program will focus on BP control, and the remaining time will help transition people to receive recommended preventive care. As part of the collaborative care model, the nurse practitioner will lead weekly meetings with a multidisciplinary clinical team about all enrolled people.
- Active Comparator: Standard self-measured blood pressure programOur hospital has a remote hypertension monitoring program that recommends daily blood pressure ascertainment for 6 weeks, at which time they are discharged and provided printed resources to encourage preventive care in the next few months. In this program, patients manually enter their self-measured BPs into the electronic medical record for the clinical team to manually review and respond.
Primary Outcome Measure
Persistent hypertension [ Time Frame: Six weeks postpartum ]
Central Contacts
- Stephanie Nunez, Research Coordinator401-274-1122
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Newport Hospital | Newport | Rhode Island | 02840 | |
| Women & Infants Hospital of Rhode Island | Providence | Rhode Island | 02903 | Adam Lewkowitz, MD, MPHS (PRINCIPAL_INVESTIGATOR) |
| South County Hospital | Wakefield | Rhode Island | 02879 | |
| Kent Hospital | Warwick | Rhode Island | 02886 | Caroline Richardson, MD (PRINCIPAL_INVESTIGATOR) |
| Landmark Hospital | Woonsocket | Rhode Island | 02895 |
Find similar trials in Newport, RI
Related Studies
- Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled TrialPHASE4 · Recruiting · Nebraska Methodist Health System · Omaha, Nebraska
- Safest Choice of Antihypertensive Regimen for Postpartum HypertensionPHASE3 · Recruiting · Loma Linda University · Loma Linda, California
- Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot ProjectPHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- IMPACT: Improving Maternal Postpartum Access to Care Through TelemedicineRecruiting · University of Texas Southwestern Medical Center · Atlanta, Georgia